Companies / Moderna, Inc.
Moderna, Inc.
Financials · FY2025
Ownership
399.2M shares outstanding · as of Jul 24, 2026
Ownership
| Insiders | 1.96% | 7,830,034 |
| 10%+ / strategic | 15.50% | 61,881,983 |
| Institutions | 62.79% | 250,682,090 |
| Public float | 19.75% | 78,841,782 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 7
View all →| Insider | % of shares | Shares |
|---|---|---|
Bancel StephaneCEOChief Executive Officer · Director | 1.55% | 6,187,791 |
Hoge StephenPresident | 0.37% | 1,477,997 |
Klinger Shannon ThymeChief Legal Officer | 0.02% | 65,782 |
Mock James MChief Financial Officer | 0.01% | 56,998 |
Nader FrancoisDirector | <0.01% | 32,781 |
Tallett Elizabeth EDirector | <0.01% | 4,761 |
Afeyan NoubarDirector | <0.01% | 3,924 |
Institutional holders 703
View all →| Holder | Value | % of shares |
|---|---|---|
| $2.14B | 7.66% | |
| $1.23B | 10.42% | |
| $1.10B | 3.94% | |
| $1.02B | 5.01% | |
| $827.06M | 7.02% | |
| $478.49M | 2.36% | |
| $461.59M | 2.28% | |
| $378.30M | 3.21% | |
| $261.60M | 2.22% | |
| $238.33M | 2.02% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Hoge Stephen Executive | Sell | Common Stock | $7.81M | -160K -9.89% | 1,457,427 0.37% of shares | medium |
| Feb 23, 2026 | Hoge Stephen Executive | Exercise | Common Stock | $2.14M | +112K +7.66% | 1,569,106 0.39% of shares | low |
| Feb 27, 2026 | Hoge Stephen Executive | Other | Common Stock | $928.3K | -18K -1.20% | 1,477,997 0.37% of shares | low |
| Feb 23, 2026 | Hoge Stephen Executive | Exercise | Common Stock | $925.5K | +48K +3.08% | 1,617,436 0.41% of shares | low |
| Mar 2, 2026 | Klinger Shannon Thyme Executive | Sell | Common Stock | $726.0K | -14K -18.87% | 59,689 0.01% of shares | medium |
| May 21, 2026 | Afeyan Noubar Director | Sell | Common Stock | $433.9K | -9K -70.24% | 3,924 <0.01% of shares | medium |
| Mar 2, 2026 | Klinger Shannon Thyme Executive | Exercise | Common Stock | $429.9K | +14K +23.26% | 73,574 0.02% of shares | low |
| Mar 5, 2026 | Mock James M Executive | Other | Common Stock | $329.7K | -6K -9.10% | 56,998 0.01% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| BAILLIE GIFFORD & CO | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
| Fmr LLC | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| MRNA | — | 60770K107 |